Similarly, CD133+ cells isolated from human primary ovarian tumor displayed higher tumorigenic capacity when injected into NOD/SCID mice and were capable of recapitulating the original heterogeneous tumor [60]. This evidence concerns the gene PROM1 and neoplasm.